An observational study in Osteoarthritis, Hip, Hip Osteoarthritis and Prosthesis Survival, sponsored by Waldemar Link GmbH & Co. KG. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-25.
Sponsored by Waldemar Link GmbH & Co. KG · Observational
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.
The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
641 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.
This study's planned enrollment of 520 is above the median of 135 across 158 observational studies indexed under Osteoarthritis, Hip.
Browse Osteoarthritis, Hip studies →Waldemar Link GmbH & Co. KG is the lead sponsor of 5 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
primary care clinic
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint,
calculated with Kaplan-Meier method.
Time frame: 10-years
Revision rates of the complete MobileLink acetabular cup system with revision for any reason except peri-prosthetic infections as the endpoint
Time frame: 3 months, 1 year, 3, 5, 7 and 10 years
Revision rates of the MobileLink acetabular cup system shell(s) with revision for any reason as the endpoint
Time frame: 3 months, 1 year, 3, 5, 7 and 10 years
Revision rates of the MobileLink acetabular cup system inserts (Ceramic, XLINKed, E-Dur) with revision for any reason as the endpoint
Time frame: 3 months, 1 year, 3, 5, 7 and 10 years
Revision rates of the combined LINK hip stem(s) with revision for any reason as the endpoint
Time frame: 3 months, 1 year, 3, 5, 7 and 10 years
Change of baseline hip functionality
measured by the Harris Hip Score (HHS) (maximum 100 points, minimum 0 points, a higher score indicates a better outcome)
Time frame: pre-operatively and at the 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Change of baseline hip functionality
measured by the Hip disability and osteoarthritis outcome score (HOOS), (maximum 100 points, minimum 0 points, a higher score indicates a better outcome)
Time frame: pre-operatively and at the 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Rate of complications and re-operations of the hip joint
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Rate of failed osteointegrated cups
radiological assessment
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Rate of failed osteointegrated stems
radiological assessment
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Change of postoperative cup position
radiological assessment
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Change of postoperative stem position
radiological assessment
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Occurence of heterotopic ossifications
radiological assessment, classified according to Brooker
Time frame: 3 months, 1 year, 3, 5, 7 and 10 year follow-up
Type and rate of complications with the used instruments related to usability and sterilization
Time frame: intraoperatively
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 3 month
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 1 year
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 3 year
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 5 year
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 7 year
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint
calculated with Kaplan-Meier method.
Time frame: 10 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Waldemar Link GmbH & Co. KG